Target intelligence / Profile preview

Gram-negative bacterial lipopolysaccharide (LPS)

Target
LPS
Molecular classification
Other
01

Overview

Gram-negative bacterial lipopolysaccharide (LPS), also known as endotoxin, is a major glycolipid component of the outer leaflet of the outer membrane of Gram-negative bacteria. It plays a critical role in maintaining the structural integrity of the bacterial cell envelope and acts as a highly effective physical and chemical permeability barrier against toxic compounds, including many antibiotics. Structurally, LPS consists of three domains: a hydrophobic lipid A moiety that anchors the molecule in the outer membrane, a core oligosaccharide, and a highly variable O-antigen polysaccharide chain exposed to the extracellular environment. The lipid A portion is highly conserved and is responsible for the endotoxic activity of LPS, triggering a robust inflammatory response in mammalian hosts via the TLR4/MD-2 receptor complex. Because of its essential role in bacterial survival and outer membrane stability, LPS is a major therapeutic target. Cationic polypeptide antibiotics, such as polymyxin B and colistin (polymyxin E), directly bind to the negatively charged lipid A phosphate groups of LPS, displacing stabilizing divalent cations (calcium and magnesium) and disrupting the outer membrane, which leads to cell lysis and bactericidal activity. Additionally, novel therapeutic strategies target the biosynthesis of LPS (e.g., LpxC inhibitors) or its transport machinery (e.g., zosurabalpin targeting the LptB2FGC complex), highlighting the central importance of LPS in combating multidrug-resistant Gram-negative bacterial infections.

Other names
LipopolysaccharideEndotoxinLipoglycanLipid AO-antigenBacterial lipopolysaccharideGram-negative bacterial outer membrane
02

Mechanism of action

Direct binding to the lipid A moiety of lipopolysaccharide, displacing divalent cations (calcium and magnesium) that stabilize the outer membrane. This disrupts membrane integrity, causing leakage of cytoplasmic contents and bactericidal activity. Additionally, novel agents can inhibit the transport of lipopolysaccharide from the inner membrane to the outer membrane by targeting the LptB2FGC complex, leading to toxic intracellular accumulation of lipopolysaccharide and cell death.

03

Biological functions

OtherImmune responseCell death
04

Disease associations

InfectionInflammationOther
05

Safety considerations

NephrotoxicityNeurotoxicityJarisch-Herxheimer reactionEndotoxemia and septic shock due to rapid bacterial lysisNeuromuscular blockade
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

Endotoxin levelLipopolysaccharide-binding proteinSoluble CD14ProcalcitoninC-reactive proteinInterleukin-6

Beyond the preview

Go deeper on Gram-negative bacterial lipopolysaccharide (LPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-negative bacterial lipopolysaccharide (LPS).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call